Testing effectiveness (Phase 2)Study completedNCT04359810What this trial is testingPlasma Therapy of COVID-19 in Severely Ill PatientsWho this might be right forSARS-CoV-2 Infection Max O'Donnell 223
Not applicableStudy completedNCT05433324What this trial is testing"Long COVID-19" on the Human BrainWho this might be right forCOVID-19Long CovidPost Acute Sequelae of COVID-19 Centre for Addiction and Mental Health 48
Not applicableStudy completedNCT05358873What this trial is testingEfficacy and Safety of Nasal Spray Solution Containing Human IgG1 Anti-COVID-19 Antibody CocktailWho this might be right forSARS CoV 2 InfectionSARS-CoV-2 Acute Respiratory Disease Chulalongkorn University 50
Not applicableUnknownNCT04486729What this trial is testingRespiratory Mechanics and Gas Exchange Characteristics in Patient With SARS-CoV-2Who this might be right forCovid19ARDS, Human Sanatorio Anchorena San Martin 15
Not applicableStudy completedNCT04667442What this trial is testingInvestigational Performance Evaluation of the Nanomix eLab® COVID-19 Rapid Antigen Panel With Samples From COVID-19 Positive and Negative Human SubjectsWho this might be right forCovid19 Nanomix 137
Early research (Phase 1)UnknownNCT04629105What this trial is testingRegenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)Who this might be right forARDS, HumanCovid19 Longeveron Inc. 70
Large-scale testing (Phase 3)Study completedNCT06291857What this trial is testingEvaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination VaccineWho this might be right forCOVID-19 Novavax 9,320
Not applicableUnknownNCT05148975What this trial is testingThe Diagnosis of Superinfections in Mechanically Ventilated Covid-19 PatientsWho this might be right forCOVID-19 PneumoniaSuperinfectionARDS, Human Brno University Hospital 150
Early research (Phase 1)Study completedNCT04350736What this trial is testingFirst in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19Who this might be right forAcute Lung Injury (ALI) Associated With COVID-19Inflammatory Lung Conditions Associated With COVID-19 Theravance Biopharma 54
Post-approval studies (Phase 4)UnknownNCT05105295What this trial is testingImmunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in People With HIV InfectedWho this might be right forCOVID-19HIV Infections China National Biotec Group Company Limited 400